vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume $13.87 -1.09 (-7.29%) (As of 12/23/2024 05:27 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends vTv Therapeutics Short Interest DatavTv Therapeutics (VTVT) has a short interest of 22,500 shares, representing 1.61% of the float (the number of shares available for trading by the public). This marks a -17.28% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 36,608 shares to cover all short positions.Current Short Interest22,500 sharesPrevious Short Interest27,200 sharesChange Vs. Previous Month-17.28%Dollar Volume Sold Short$360,900.00Short Interest Ratio0.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares3,190,000 sharesFloat Size1,400,000 sharesShort Percent of Float1.61%Today's Trading Volume11,631 sharesAverage Trading Volume36,608 sharesToday's Volume Vs. Average32% Short Selling vTv Therapeutics? Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTVT Short Interest Over TimeVTVT Days to Cover Over TimeVTVT Percentage of Float Shorted Over Time Ad InvestorPlaceWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning vTv Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202422,500 shares $360,900.00 -17.3%1.6%0.7 $16.04 11/15/202427,200 shares $469,200.00 -5.9%1.9%0.9 $17.25 10/31/202428,900 shares $396,508.00 -0.3%2.2%1 $13.72 10/15/202429,000 shares $386,860.00 -7.9%2.3%1 $13.34 9/30/202431,500 shares $424,620.00 +1.6%2.4%1.1 $13.48 9/15/202431,000 shares $442,060.00 -6.3%2.4%1 $14.26 Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202433,100 shares $520,001.00 -13.1%2.6%1.2 $15.71 8/15/202438,100 shares $513,969.00 +34.6%3.0%1.5 $13.49 7/31/202428,300 shares $429,028.00 +45.9%2.2%1.4 $15.16 7/15/202419,400 shares $473,166.00 -1.0%1.5%1.6 $24.39 6/30/202419,600 shares $346,136.00 -10.5%1.5%2.6 $17.66 6/15/202421,900 shares $460,338.00 +17.7%1.7%3.4 $21.02 5/31/202418,600 shares $433,938.00 -21.9%1.4%1.8 $23.33 5/15/202423,800 shares $615,944.00 -10.5%1.8%0.4 $25.88 4/30/202426,600 shares $742,140.00 -7.6%3.2%0.4 $27.90 4/15/202428,800 shares $720,000.00 -10.6%3.4%0.4 $25.00 3/31/202432,200 shares $757,666.00 -43.7%6.1%0.4 $23.53 3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00 2/29/202438,000 shares $666,900.00 -12.0%8.4%0.5 $17.55 2/15/202443,200 shares $415,152.00 -39.1%6.5%1.4 $9.61 1/31/202470,900 shares $596,269.00 +78.6%10.7%2.2 $8.41 1/15/202439,700 shares $363,255.00 -20.8%6.0%1.5 $9.15 12/31/202350,100 shares $576,150.00 +27.8%N/A2.3 $11.50 12/15/202339,200 shares $343,000.00 +10.4%5.9%2 $8.75 11/30/202335,500 shares $507,295.00 +25.0%5.3%2.1 $14.29 11/15/202328,400 shares $398,736.00 -97.6%4.3%7.7 $14.04 10/31/20231,180,000 shares $484,980.00 -6.4%4.4%7.1 $0.41 10/15/20231,260,000 shares $587,286.00 +4.1%4.7%7.1 $0.47 9/30/20231,210,000 shares $578,380.00 -4.0%4.5%6.7 $0.48 9/15/20231,260,000 shares $560,826.00 +4.1%4.6%7.6 $0.45 8/31/20231,210,000 shares $617,100.00 -13.6%4.4%5.8 $0.51 8/15/20231,400,000 shares $998,760.00 +15.7%5.1%6.2 $0.71 7/31/20231,210,000 shares $817,960.00 -4.7%4.4%8.5 $0.68 7/15/20231,270,000 shares $915,670.00 -1.6%4.6%9.8 $0.72 6/30/20231,290,000 shares $954,342.00 +7.5%4.7%10.2 $0.74 6/15/20231,200,000 shares $911,880.00 -3.2%4.4%9.6 $0.76 5/31/20231,240,000 shares $979,600.00 +6.9%4.5%15.1 $0.79 5/15/20231,160,000 shares $996,208.00 -1.7%4.2%12.6 $0.86 4/30/20231,180,000 shares $908,600.00 -0.8%4.3%13.4 $0.77 4/15/20231,190,000 shares $880,838.00 -0.8%4.4%13.6 $0.74Wall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning 3/31/20231,200,000 shares $969,360.00 -1.6%4.4%12.2 $0.81 3/15/20231,220,000 shares $964,044.00 +8.9%4.5%11.5 $0.79 2/28/20231,120,000 shares $907,200.00 No Change4.1%10.3 $0.81 2/15/20231,120,000 shares $985,600.00 -4.3%4.1%17.3 $0.88 1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95 1/15/20231,130,000 shares $921,967.00 -4.2%4.1%16.4 $0.82 12/30/20221,180,000 shares $782,104.00 +8.3%4.3%17.9 $0.66 12/15/20221,090,000 shares $775,971.00 +2.8%4.0%18.1 $0.71 11/30/20221,060,000 shares $873,864.00 -1.9%3.9%15.5 $0.82 11/15/20221,080,000 shares $950,508.00 -3.6%4.0%15.2 $0.88 10/31/20221,120,000 shares $967,680.00 No Change4.1%10.2 $0.86 10/15/20221,120,000 shares $958,048.00 -8.2%4.1%6.3 $0.86 9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97 9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15 8/31/20221,270,000 shares $1.35 million -5.9%8.1%4.4 $1.06 8/15/20221,350,000 shares $1.85 million -19.2%6.1%1.5 $1.37 7/31/20221,670,000 shares $1.50 million +21.9%9.2%1.8 $0.90 7/15/20221,370,000 shares $934,340.00 -9.3%7.5%1.6 $0.68 6/30/20221,510,000 shares $1.13 million -15.2%8.3%1.8 $0.75 6/15/20221,780,000 shares $1.34 million +17.1%9.8%2.1 $0.76 5/31/20221,520,000 shares $837,520.00 -13.1%5.3%1.8 $0.55 5/15/20221,750,000 shares $743,750.00 No Change6.1%6.7 $0.43 4/30/20221,750,000 shares $1.21 million -0.6%6.1%7.5 $0.69 4/15/20221,760,000 shares $1.39 million +1.2%6.1%7.3 $0.79 3/31/20221,740,000 shares $1.26 million +3.6%6.1%6.9 $0.72 3/15/20221,680,000 shares $924,840.00 -13.0%5.9%5.7 $0.55 2/28/20221,930,000 shares $1.58 million +19.1%6.7%6.2 $0.82 2/15/20221,620,000 shares $1.20 million -0.6%5.7%5.1 $0.74 1/31/20221,630,000 shares $1.17 million +1.2%5.4%4.4 $0.72 1/15/20221,610,000 shares $1.42 million -5.3%5.3%3.5 $0.88 12/31/20211,700,000 shares $1.69 million -6.1%N/A2.8 $1.00 12/15/20211,810,000 shares $2.03 million -13.4%6.0%1.1 $1.12 11/30/20212,090,000 shares $2.59 million -2.3%8.0%1.1 $1.24 11/15/20212,140,000 shares $3.32 million +9.2%8.2%1.2 $1.55 10/29/20211,960,000 shares $2.80 million -22.8%8.4%1.1 $1.43 10/15/20212,540,000 shares $3.73 million +15.5%10.8%1.5 $1.47 9/30/20212,200,000 shares $3.37 million +39.2%9.4%1.4 $1.53 9/15/20211,580,000 shares $2.73 million -8.7%6.7%1.1 $1.73 8/31/20211,730,000 shares $3.24 million -14.4%7.4%1.6 $1.87 8/13/20212,020,000 shares $3.72 million -4.3%8.6%1.6 $1.84 7/30/20212,110,000 shares $4.05 million +2.9%9.0%1.4 $1.92 7/15/20212,050,000 shares $4.12 million -10.1%8.7%1.3 $2.01 6/30/20212,280,000 shares $5.20 million -5.4%10.3%0.4 $2.28 6/15/20212,410,000 shares $6.17 million +5.7%10.9%0.4 $2.56 5/28/20212,280,000 shares $5.61 million -11.3%10.7%0.4 $2.46 5/14/20212,570,000 shares $5.83 million -17.4%12.2%0.5 $2.27 4/30/20213,110,000 shares $8.21 million -39.9%14.8%0.5 $2.64 4/15/20215,170,000 shares $17.22 million +138.3%24.8%0.7 $3.33 3/31/20212,170,000 shares $5.82 million -4.4%10.4%0.7 $2.68 3/15/20212,270,000 shares $6.13 million -9.9%11.0%0.7 $2.70Wall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning 2/26/20212,520,000 shares $6.40 million -17.7%15.9%0.5 $2.54 2/12/20213,060,000 shares $8.26 million -7.0%21.8%0.6 $2.70 1/29/20213,290,000 shares $6.58 million +12.3%25.4%0.7 $2.00 1/15/20212,930,000 shares $6.30 million +5.0%22.6%0.9 $2.15 12/31/20202,790,000 shares $5.38 million -26.8%21.5%1 $1.93 12/15/20203,810,000 shares $11.32 million +73.2%29.4%1.4 $2.97 11/30/20202,200,000 shares $4.73 million +5.3%18.2%3.4 $2.15 10/30/20201,940,000 shares $3.38 million -2.0%15.3%3.9 $1.74 10/15/20201,980,000 shares $3.45 million -1.0%16.5%4.2 $1.74 9/30/20202,000,000 shares $3.54 million +0.5%16.7%4.1 $1.77 9/15/20201,990,000 shares $3.88 million +4.7%16.6%3.8 $1.95 8/31/20201,900,000 shares $3.95 million +8.6%15.8%3.4 $2.08 8/14/20201,750,000 shares $4.25 million -0.6%18.7%2.9 $2.43 7/31/20201,760,000 shares $4.14 million -7.4%18.8%2.6 $2.35 7/15/20201,900,000 shares $4.45 million -9.5%21.8%4.4 $2.34 6/30/20202,100,000 shares $4.68 million +16.7%24.1%5.1 $2.23 6/15/20201,800,000 shares $4.99 million +0.6%20.6%4.8 $2.77 5/29/20201,790,000 shares $5.16 million +0.6%20.5%6.4 $2.88 5/15/20201,780,000 shares $5.30 million +5.3%20.4%5.5 $2.98 4/30/20201,690,000 shares $3.58 million +10.5%20.1%2.4 $2.12 4/15/20201,530,000 shares $3.35 million +3.4%19.3%2.1 $2.19 3/31/20201,480,000 shares $2.83 million +5.9%18.8%1.8 $1.91 3/13/20201,397,600 shares $2.74 million +0.6%17.7%4.7 $1.96 2/28/20201,390,000 shares $2.39 million +2.2%17.6%1.6 $1.72 2/14/20201,360,000 shares $3.67 million +6.3%31.3%1.7 $2.70 1/31/20201,280,000 shares $4.25 million -2.3%33.9%1.8 $3.32 1/15/20201,310,000 shares $4.17 million No Change26.0%4.3 $3.18 12/31/20191,310,000 shares $3.05 million +4.8%26.0%5.8 $2.33 VTVT Short Interest - Frequently Asked Questions What is vTv Therapeutics' current short interest? Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 22,500 shares of VTVT short. 1.61% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest. What is a good short interest ratio for vTv Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTVT shares currently have a short interest ratio of 1.0. Learn More on vTv Therapeutics's short interest ratio. What is a good short interest percentage for vTv Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.61% of vTv Therapeutics' floating shares are currently sold short. Is vTv Therapeutics' short interest increasing or decreasing? vTv Therapeutics saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 22,500 shares, a decline of 17.3% from the previous total of 27,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is vTv Therapeutics' float size? vTv Therapeutics currently has issued a total of 3,190,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 1,400,000 shares. How does vTv Therapeutics' short interest compare to its competitors? 1.61% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to vTv Therapeutics: Opthea Limited (0.12%), ProQR Therapeutics (0.23%), Amarin Co. plc (4.37%), Alector, Inc. (7.14%), ADC Therapeutics SA (3.11%), Coherus BioSciences, Inc. (26.66%), Gossamer Bio, Inc. (2.82%), Organigram Holdings Inc. (3.44%), Genfit S.A. (0.13%), Innate Pharma S.A. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short vTv Therapeutics stock? Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading down $1.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against vTv Therapeutics? A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further. How often is vTv Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Opthea Short Interest ProQR Therapeutics Short Interest Amarin Short Interest Alector Short Interest ADC Therapeutics Short Interest Coherus BioSciences Short Interest Gossamer Bio Short Interest Organigram Short Interest Genfit Short Interest Innate Pharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTVT) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTVT Stock Alerts